Scientists at Queensland Brain Institute find noninvasive technique slows progression of Alzheimer’s disease in mice Australian researchers say they have made a promising step in the future treatment of Alzheimer’s disease after discovering ultrasound can effectively and safely deliver drugs to the damaged brain. Show More Summary
A new study has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with the progression of Alzheimer's disease.
(King's College London) A new study published in PLOS Medicine's Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with the progression of Alzheimer's disease.
Alzheimer's disease i s the only one of the top leading causes of death whose progression can't be slowed down or stopped. The neurodegenerative disease affects about 5.5 million Americans, a number that's expected to balloon to 13.8...Show More Summary
(PLOS) A new study of Alzheimer's disease by Fiona Kerr and Linda Partridge at University College London, uses mouse and fruit fly models to show that Keap1, which inhibits the protective protein Nrf2, is a promising target for new preventative drugs for Alzheimer's and other neurodegenerative diseases. Show More Summary
(Amplify Public Affairs) UsAgainstAlzheimer's, which works collaboratively with industry partners to see near- and long-term progress against this destructive disease, applauds the vast investment of Merck, the diligence of the manyShow More Summary
Not a single medicine has been shown to slow the progression of the disease, so researchers are taking an aggressive new approach.
Researchers have kept trying despite a 99 percent failure rate.
The progression of Alzheimer's disease, happening in the midst of aging in general, and often other unrelated neurodegeneration as well, is so complex and sweeping that every research group focuses down on just one part of the whole....Show More Summary
Findings from a recent study published in JAMA Psychiatry have found a link between delirium and the progression of Alzheimer’s disease. Delirium occurs when patients become confused and disoriented, and is prevalent in elderly patients. Show More Summary
(JCI Journals) In Alzheimer's disease and Parkinson's disease, loss of the sense of smell often precedes classical symptoms of cognitive or motor dysfunction. In work published this week in the JCI, a team led by Jacob Hooker at Harvard...Show More Summary
In December, Lilly announced that trials showed a drug intended to slow the progression of Alzheimer's disease did not work.
(Amplify Public Affairs) In a letter released today by UsAgainstAlzheimer's, Co-Founder and Chairman George Vradenburg said the negative clinical trial of a once-promising Alzheimer's drug, Solanezumab, which showed clinically insignificant...Show More Summary
Alzheimer’s disease is one of the top causes of death in the U.S., but how quickly can it progress and what is the outlook for people who are diagnosed?
Alzheimer's disease is both an amyloidosis and a tauopathy. The dysfunction and death of neurons is driven by rising levels of amyloid-? and altered forms of tau, both of which form solid deposits in brain tissue. The accumulation of...Show More Summary
Psychologists believe they can identify progressive changes in work of artists who went on to develop Alzheimer’s disease The first subtle hints of cognitive decline may reveal themselves in an artist’s brush strokes many years before dementia is diagnosed, researchers believe. Show More Summary
An experimental treatment for Alzheimer's failed again in a widely anticipated study, disappointing many who had hoped drugmaker Eli Lilly had finally found a way to slow the progression of the mind-robbing disease. The drug did not work better than a placebo treatment in a study of more than...
Final-stage results dash hopes that solanezumab, an injectable antibody, would provide treatment breakthrough A drug that was seen as a strong contender to slow the progression of Alzheimer’s disease has failed to deliver in the final...Show More Summary
Alzheimer's disease is a progressive disease that destroys memory and other important mental functions. Many people who have relatives with this disease worry that it may run in the family. Does having a family member with Alzheimer's disease increase your risk of developing it? In this Mayo Clinic Minute, reporter Vivien Williams talks to Dr. […]
Dementia is now the commonest cause of death in England and Wales, and although Alzheimer’s was first identified more than a century ago, effective treatments have proved elusive. But progress may now be in sight Related: Sea Hero Quest: the mobile phone game helping fight dementia Most of us forget names, dates or places from time to time. Show More Summary